Suppression of fibroblast cell cycle progression in G1 phase by N- acetylcysteine

Toxicology and Applied Pharmacology

Volumn 149, Issue 2, 1998, Pages 210-216

  Sekharam, Madhavi ^a   Trotti, Andrea ^b   Cunnick, Jess M ^a   Wu, Jie ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; CYCLIN D1; CYCLINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL CYCLE G1 PHASE; CELL STRAIN 3T3; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS INHIBITION; FETAL CALF SERUM; MITOSIS INHIBITION; MOUSE; NONHUMAN;

ANIMALIA; BOVINAE;

EID: 0031946528     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1997.8361     Document Type: Article

References (18)

1. Bae Y. S., Kang S. W., Seo M. S., Baines I. C., Tekle E., Chock P. B., Rhee S. G. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. J. Biol. Chem. 272:1997;217-221.
2. Castor C. W., Smith E. M., Bignall M. C., Hossler P. A., Sisson T. H. Preparation and bioassay of connective tissue activating peptide III and its isoforms. Methods Enzymol. 198:1991;408-416.
3. Chen Q, Olashaw N., Wu J. Participation of reactive oxygen species in the lysophosphatidic acid-stimulated mitogen-activated protein kinase kinase activation pathway. J. Biol. Chem. 270:1995;28499-28502.
4. Cotgreave I. A. N. Adv. Pharmacol. 38:1997;205-227.
5. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1997;1-20.
6. De Flora S., Cesarone C. F., Balansky R. M., Albini A., D'Agostini F., Bennicelli C., Bagnasco M., Camoirano A., Scatolini L., Rovida A., Izzotti A. Chemopreventive properties and mechanisms ofN. J. Cell. Biochem. Suppl. 22:1995;33-41.
7. Fanger G. R., Gerwins P., Widmann C., Jarpe M. B., Johnson G. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: Upstream regulators of the c-jun. Curr. Opin. Genet. Dev. 7:1997;67-74.
8. Lavoie J. N., L'Allemain G., Brunet A., Muller R., Pouyssegur J. Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway. J. Biol. Chem. 271:1996;20608-20616.
9. Lo Y. Y. C., Cruz T. F. Involvement of reactive oxygen species in cytokine and growth factor induction of c-fos. J. Biol. Chem. 270:1995;11727-11730.
10. Pages G., Lenormand P., L'Allemain G., Chambard J. C., Meloche S., Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA. 90:1993;8319-8323.
11. Payne D. M., Rossomando A. J., Martino P., Erikson A. K., Her J-H., Shabanowitz J., Hunt D. F., Weber M. J., Sturgill T. W. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:1991;885-892.
12. Schreck R., Baeuerle P. A role for oxygen radicals as second messengers. Trends Cell Biol. 1:1991;39-42.
13. Seger R., Krebs E. G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
14. Sen C. K., Packer L. Antioxidant and redox regulation of gene transcription. FASEB J. 10:1996;709-720.
15. Sherr C. J. G1 phase progression: Cycling on cue. Cell. 79:1994;551-555.
16. Sherr C. J. Cancer cell cycles. Science. 274:1996;1672-1677.
17. 22. Science. 270:1995;296-299.
18. van Zandwijk N. N. J. Cell. Biochem. Suppl. 22:1995;24-32.